BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 15347821)

  • 1. Indicators of malignancy of canine adrenocortical tumors: histopathology and proliferation index.
    Labelle P; Kyles AE; Farver TB; De Cock HE
    Vet Pathol; 2004 Sep; 41(5):490-7. PubMed ID: 15347821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
    Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
    Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
    Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
    Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.
    Takehara K; Sakai H; Shono T; Irie J; Kanetake H
    Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas.
    Iino K; Sasano H; Yabuki N; Oki Y; Kikuchi A; Yoshimi T; Nagura H
    Mod Pathol; 1997 Sep; 10(9):901-7. PubMed ID: 9310953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.
    Schmitt A; Saremaslani P; Schmid S; Rousson V; Montani M; Schmid DM; Heitz PU; Komminoth P; Perren A
    Histopathology; 2006 Sep; 49(3):298-307. PubMed ID: 16918977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cushing's syndrome due to a large adrenocortical adenoma with histological features simulating ACTH-independent macronodular adrenocortical hyperplasia.
    Karasawa R; Hotta M; Aiba M; Takano K
    Pathol Int; 2004 Apr; 54(4):273-8. PubMed ID: 15028030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis.
    Stojadinovic A; Brennan MF; Hoos A; Omeroglu A; Leung DH; Dudas ME; Nissan A; Cordon-Cardo C; Ghossein RA
    Mod Pathol; 2003 Aug; 16(8):742-51. PubMed ID: 12920217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adrenocortical tumors: mitotic index and nuclear size as criteria for differential diagnosis and prognosis].
    Poliakova GA; Kazantseva IA; Kalinin AP; Perov AI; Bokova EV
    Arkh Patol; 1999; 61(3):30-4. PubMed ID: 10476345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
    Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
    Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine hyperadrenocorticism due to adrenocortical neoplasia. Pretreatment evaluation of 41 dogs.
    Reusch CE; Feldman EC
    J Vet Intern Med; 1991; 5(1):3-10. PubMed ID: 1850483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative aspects of Cushing's syndrome in dogs and cats.
    Feldman EC; Nelson RW
    Endocrinol Metab Clin North Am; 1994 Sep; 23(3):671-91. PubMed ID: 7805662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?
    Sturgeon C; Shen WT; Clark OH; Duh QY; Kebebew E
    J Am Coll Surg; 2006 Mar; 202(3):423-30. PubMed ID: 16500246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors.
    Terzolo M; Boccuzzi A; Bovio S; Cappia S; De Giuli P; Alì A; Paccotti P; Porpiglia F; Fontana D; Angeli A
    Urology; 2001 Jan; 57(1):176-82. PubMed ID: 11164177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
    de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
    Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic and immunohistochemical classification of 41 bovine adrenal gland neoplasms.
    Grossi AB; Leifsson PS; Jensen HE; Vainer B; Iburg T
    Vet Pathol; 2013 May; 50(3):534-42. PubMed ID: 23242804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical analysis of 103 cases of adrenal incidentaloma].
    Tao H; Lu ZL; Li HZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):172-5. PubMed ID: 12905714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing's syndrome associated with bilateral adrenal adenomas.
    Mimou N; Sakato S; Nakabayashi H; Saito Z; Takeda R; Matsubara F
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):245-54. PubMed ID: 3969816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with adrenocortical neoplasms in childhood.
    Neblett WW; Frexes-Steed M; Scott HW
    Am Surg; 1987 Mar; 53(3):117-25. PubMed ID: 3826904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior.
    Papotti M; Volante M; Duregon E; Delsedime L; Terzolo M; Berruti A; Rosai J
    Am J Surg Pathol; 2010 Jul; 34(7):973-83. PubMed ID: 20534995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.